Search - tctmd.com

Displaying 321 - 340 of 884

Sort: Relevancy | Date

News Conference News ACC 2023

Too Many HF Patients Exiting Rural Hospitals Miss Out on Endorsed Therapies

Caitlin E. Cox

February 23, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Caitlin E. Cox

February 10, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

Presentation Miami Valves 2023

Gender and Racial Disparities in SCD Prevention

Presenter: Litsa K. Lambrakos

February 03, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

Less Than One in Five CVD Trials Led by Women

Michael O'Riordan

January 25, 2023

News Daily News

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

Todd Neale

January 23, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Daily News

More Hints That Cardiac Abnormalities Resolve Fully After MIS-C

Shelley Wood

January 16, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

Shelley Wood

January 03, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

Advertisement

Too Many HF Patients Exiting Rural Hospitals Miss Out on Endorsed Therapies

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

February 2023 News Roundup

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Vast Majority of HFrEF Patients Eligible for Vericiguat

Gender and Racial Disparities in SCD Prevention

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

Less Than One in Five CVD Trials Led by Women

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

More Hints That Cardiac Abnormalities Resolve Fully After MIS-C

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

TCTMD’s Top 10 Most Popular Stories for December 2022

The Biggest News of 2022: TCTMD’s Top 10

December 2022 News Roundup

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content